Liquidia Corp

1. 1

   Election of Three Class II Directors

   ManagementBoard: FOR

   Elect three Class II directors — Katie Rielly-Gauvin, Ramandeep Singh, and David Johnson — to serve three-year terms expiring at the 2029 annual meeting.

2. 2

   Ratify Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for 2026

   ManagementBoard: FOR

   Ratify the Audit Committee’s appointment of PricewaterhouseCoopers LLP as Liquidia’s independent registered public accounting firm for the year ending December 31, 2026.

3. 3

   Advisory Vote on the Compensation of Our Named Executive Officers (Say-on-Pay

   ManagementBoard: FOR

   A non-binding advisory vote to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.

   More detail

   This non-binding advisory proposal asks shareholders to approve the company’s disclosed 2025 compensation for its named executive officers (NEOs). Management is seeking approval to reaffirm its compensation philosophy — which it describes as pay-for-performance, market-competitive, and aligned with long-term stockholder interests through equity awards — and to validate the decisions of the Compensation Committee. The proposal is contextualized by a very strong 2025 operational year: FDA approval and commercial launch of YUTREPIA, rapid revenue growth, early profitability, and a Compensation Committee-approved maximum (200%) payout under the annual bonus plan. Material elements driving the 2025 compensation outcome included large RSU/PSU awards (with PSUs conditioned on the first commercial sale of YUTREPIA, a milestone the company achieved), time-based vesting, and a cash bonus program that delivered at the maximum level based on overachievement of corporate goals. The Compensation Committee engaged an independent consultant (FW Cook), used peer benchmarking, and certified that the company’s pay practices and governance (including a clawback policy and review of risks) are appropriate, which the Board cites as rationale for its FOR recommendation. Because the vote is advisory, it does not bind the Board but provides important stockholder feedback that the Board and Compensation Committee will consider in future compensation determinations. From a governance perspective, the company frames this as confirmation that its executive pay structure supported the launch and commercialization priorities and was necessary to attract, retain and motivate leadership during a transformational commercial year. Potential investor concerns include the scale of equity awards and high bonus payouts in a short period; management’s counter-argument is that payouts were earned via pre‑specified performance measures tied to commercial and pipeline milestones and that equity grants align executives’ interests with long-term value creation. Investors evaluating the proposal should weigh the demonstrable operational outcomes in 2025 against ongoing oversight, the non-binding nature of the vote, and whether the disclosed pay practices appropriately calibrate risk and long-term alignment.

Upcoming shareholder meetings at Liquidia Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Liquidia Corp 2026 annual meeting?

Liquidia Corp (LQDA) holds its 2026 annual shareholder meeting on Tuesday, June 16, 2026.

What is the record date for the Liquidia Corp 2026 meeting?

The record date for the Liquidia Corp 2026 meeting is Monday, April 20, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Liquidia Corp's 2026 meeting?

The board is presenting 3 director nominees at the Liquidia Corp 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Liquidia Corp 2026 meeting?

Shareholders will vote on 3 proposals at the Liquidia Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.